SCHEMBL777474

SCHEMBL777474

Cc1ccc(S(=O)(=O)OCC(C)C)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.45
STAT3 P40763 1/20 0.43
ALDH1A1 P00352 4/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
GBA1 P04062 1/20 0.42
CA2 P00918 4/20 0.42
CA9 Q16790 4/20 0.42
CA1 P00915 3/20 0.42
CA12 O43570 2/20 0.42
CA7 P43166 2/20 0.42
CA3 P07451 1/20 0.42
CA6 P23280 1/20 0.42
CA5A P35218 1/20 0.42
CA5B Q9Y2D0 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
VDR P11473 1/20 0.41
LMNA P02545 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4757045 0.89 GAA (0.45) GAASTAT3ALDH1A1CYP3A4CYP2C9
SCHEMBL4753668 0.89 GAA (0.45) GAASTAT3ALDH1A1CYP3A4CYP2C9
SCHEMBL4753667 0.89 GAA (0.45) GAASTAT3ALDH1A1CYP3A4CYP2C9
SCHEMBL2176311 0.89 GAA (0.45) GAASTAT3ALDH1A1CYP3A4CYP2C9
Glycine SCHEMBL14993353 0.87 STAT3 (0.45) GAASTAT3ALDH1A1GBA1CA2
SCHEMBL4295792 0.86 CA2 (0.43) GAASTAT3ALDH1A1CYP3A4CYP2C9
SCHEMBL4383361 0.86 CA2 (0.43) GAASTAT3ALDH1A1CYP3A4CYP2C9
SCHEMBL4383356 0.86 CA2 (0.43) GAASTAT3ALDH1A1CYP3A4CYP2C9
SCHEMBL21114486 0.85 GAA (0.42) GAASTAT3ALDH1A1CYP3A4CYP2C9
SCHEMBL21114440 0.85 GAA (0.42) GAASTAT3ALDH1A1CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 334 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122011012-A (S) -tert-butyl ((2-methyl-7- (trimethylsilyl) hept-6-alkyne-1-yl) oxy) diphenyl silane and synthesis method and application thereof 山东省农业科学院 2026-05-12 CN claimed
CN-118501280-A Detection method and application of sulfonate impurities in bulk drug 上海市计量测试技术研究院(中国上海测试中心、华东国家计量测试中心、上海市计量器具强制检定中心) 2024-08-16 CN claimed
CN-117890516-A Method for detecting benzenesulfonate genotoxic impurities in cisatracurium besylate drug 白璧炜 2024-04-16 CN claimed
US-10981871-B2 Methods for preparing N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and polymorphic form C ACADIA PHARMACEUTICALS INC. (US) 2021-04-20 US claimed
CN-102827319-B The preparation method of a kind of vanadium series catalyst and preparation method thereof and ethylene-propylene copolymer CHANGCHUN INSTITUTE OF APPLIED CHEMISTRY CHINESE ACADEMY OF SCIENCES (CN) 2015-08-05 CN claimed
CN-102627708-B Preparation method for high-activity Ziegler Natta catalyst and application thereof CHANGCHUN APPLIED CHEMISTRY 2014-02-12 CN claimed
CN-102627712-B Preparation method and application of Ziegler Natta catalyst for propylene polymerization CHANGCHUN APPLIED CHEMISTRY 2014-02-12 CN claimed
CN-102617763-B Preparation method of ultrahigh molecular weight polyethylene CHANGCHUN APPLIED CHEMISTRY 2014-02-12 CN claimed
CN-102827319-A Vanadium catalyst and preparation method of vanadium catalyst as well as preparation method of ethylene-propylene copolymer CHANGCHUN APPLIED CHEMISTRY 2012-12-19 CN claimed
CN-102627712-A Preparation method and application of Ziegler Natta catalyst for propylene polymerization CHANGCHUN APPLIED CHEMISTRY 2012-08-08 CN claimed
CN-102627708-A Preparation method for high-activity Ziegler Natta catalyst and application thereof CHANGCHUN APPLIED CHEMISTRY 2012-08-08 CN claimed
CN-102617763-A Preparation method of ultrahigh molecular weight polyethylene CHANGCHUN APPLIED CHEMISTRY 2012-08-01 CN claimed
CN-122095297-A Composition for forming cured film, alignment material, and phase difference material 2026-05-26 CN disclosed
CN-122029478-A Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element 日产化学株式会社 2026-05-12 CN disclosed
CN-122011012-A (S) -tert-butyl ((2-methyl-7- (trimethylsilyl) hept-6-alkyne-1-yl) oxy) diphenyl silane and synthesis method and application thereof 山东省农业科学院 2026-05-12 CN disclosed
US-20250257265-A1 LIQUID CRYSTAL ALIGNING AGENT, LIQUID CRYSTAL ALIGNMENT FILM AND LIQUID CRYSTAL DISPLAY ELEMENT NISSAN CHEMICAL CORPORATION (JP) 2025-08-14 US disclosed
US-4072746-A CARDIOTONIC AGENTS STERLING DRUG INC. (US) 1978-02-07 US disclosed
US-4012397-A 2-Benzoyl-3-amino-pyridines DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DT) 1977-03-15 US disclosed
US-4004012-A 3-Cyano-5-(pyridinyl)-2(1H)-pyridinones STERLING DRUG INC. (US) 1977-01-18 US disclosed
US-3969361-A 2-Benzoyl-3-amino-pyridines DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DT) 1976-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10981871-B2 Methods for preparing N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and polymorphic form C NR3C2, CYP4A22, NR2C2 GAA 4610/4885STAT3 3903/4885ALDH1A1 3967/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.